By combining scientific expertise, advanced manufacturing, and artificial intelligence, we accelerate the discovery and development of new therapies for patients in Canada and around the world.
Innovating for Patients in Canada and beyond
Our Toronto Campus is one of the largest biomanufacturing site in Canada and a major hub for scientific innovation.
More than 300 scientists and researchers work on next-generation medicines.
The campus also hosts Sanofi’s North American Centres of Excellence for vaccine and biologics research and manufacturing.
Our Pipeline
5
Therapeutic areas
61
Compounds in clinical development
20
Clinical trials in phase 3
Leading R&D Investment in Canada
We rank among the top three investors in pharmaceutical and biotechnology research in Canada.
Our sustained investment supports:
- Patient access to innovative therapies
- Domestic biomanufacturing capacity
- Development of scientific talent
- Canada’s life sciences ecosystem
Science and Innovation Stories
Discover breakthrough moments shaping our journey to transform the future of healthcare for patients.
Designing Trials That Reflect Real Lives
Shape Matters: Inside Molecular Clamp Vaccines
How Sanofi’s Blood-Brain Barrier Shuttle is Rewriting the Script for Rare Diseases
How Artificial Intelligence Is Accelerating Research and Development
Artificial intelligence is transforming how new medicines are discovered and developed. By combining data science with biomedical research, we use AI to accelerate target discovery, improve drug design, and model virtual patient populations.
Our ambition is to halve the time needed to bring innovative medicines to patients.
Our Pipeline
Clinical Trials
